Proxima Research International Executive and Leadership Team

Oleksandr Khraban, the Chief Executive Officer at Proxima Research International, directs the overarching corporate strategy and long-term vision for the organization. By aligning pharmaceutical market intelligence with client needs, the Chief Executive Officer drives sustainable growth across international markets. This leadership role involves constant engagement with the Board to ensure fiscal health and operational excellence. Oleksandr Khraban maintains a sharp focus on expanding the company footprint within the competitive pharmaceutical landscape. Through rigorous oversight of high-level business initiatives, the Chief Executive Officer secures market leadership and fosters innovation. The executive prioritizes the development of scalable data solutions that empower pharmaceutical manufacturers to navigate complex regulatory environments. Ultimately, the Chief Executive Officer ensures that the company remains at the forefront of industry advancements, consistently delivering value to stakeholders while maintaining a robust competitive advantage in the global healthcare sector.

Oleksii Bedun, the Group Chief Financial Officer at Proxima Research International, directs the financial planning, reporting, and capital allocation strategies for the entire organization. Overseeing the fiscal health of the company, the Group Chief Financial Officer ensures that resources are deployed efficiently to support growth in the pharmaceutical market. This role involves managing complex budgeting processes and ensuring compliance with international financial regulations. Oleksii Bedun drives the development of financial models that provide insights into revenue performance and cost management. By collaborating with the executive team, the Group Chief Financial Officer facilitates informed decision-making regarding investments and market expansion. The executive monitors financial risks and implements strategies to mitigate potential threats to profitability. Through rigorous financial oversight, the Group Chief Financial Officer maintains the stability required to sustain long-term operations and support the ongoing development of innovative pharmaceutical intelligence solutions across all global business units.

Nataliya Tadeyeva, the Chief Operating Officer (Up To 600 Employees In 5 Countries) at Proxima Research International, manages the daily operational workflows and cross-border service delivery. Overseeing the execution of business processes across multiple international locations, the Chief Operating Officer (Up To 600 Employees In 5 Countries) ensures that service quality remains consistent for all pharmaceutical clients. This role involves streamlining internal procedures to improve efficiency and reduce operational bottlenecks. Nataliya Tadeyeva drives the coordination between regional teams to ensure that project timelines and deliverables meet strict industry standards. By optimizing the operational framework, the Chief Operating Officer (Up To 600 Employees In 5 Countries) enables the company to scale effectively while maintaining high levels of client satisfaction. The executive works to integrate operational best practices across all five countries of operation. Through proactive management of resources and workflows, the Chief Operating Officer (Up To 600 Employees In 5 Countries) supports the overall mission of delivering reliable pharmaceutical market intelligence.

Artem Andrushchenko, the Chief Information Officer at Proxima Research International, manages the integrity and security of critical pharmaceutical data assets. Overseeing the digital infrastructure, the Chief Information Officer ensures seamless data flow across all regional operations. This role involves architecting secure systems that support complex analytics and reporting requirements for pharmaceutical clients. Artem Andrushchenko drives the implementation of advanced information management protocols to protect sensitive industry intelligence. By optimizing data architecture, the Chief Information Officer enhances the speed and accuracy of market insights provided to partners. The executive collaborates with other leadership members to integrate information systems with broader business objectives, ensuring that technology supports the company mission. Through continuous monitoring of digital threats and system performance, the Chief Information Officer maintains a resilient information environment that facilitates reliable decision-making for pharmaceutical stakeholders worldwide.

Dmitriy Dorosh, the Chief Technology Officer at Proxima Research International, leads the development of proprietary software platforms and analytical tools. Architecting scalable technical solutions, the Chief Technology Officer drives the evolution of the company product suite to meet changing pharmaceutical industry demands. This role involves managing the engineering teams responsible for building high-performance applications that process vast amounts of market data. Dmitriy Dorosh ensures that all technological advancements align with the strategic goals of the organization. By fostering a culture of continuous improvement, the Chief Technology Officer accelerates the deployment of new features and capabilities. The executive works closely with the product development units to translate complex market requirements into functional, user-friendly software. Through the application of cutting-edge technology, the Chief Technology Officer empowers pharmaceutical clients to gain actionable insights, thereby solidifying the company position as a leader in pharmaceutical technology innovation.

Anatolii Shapovalov, the Chief Human Resources Officer at Proxima Research International, manages the talent acquisition and organizational development strategies necessary for a high-growth pharmaceutical firm. Overseeing the recruitment of specialized professionals, the Chief Human Resources Officer ensures that the workforce possesses the expertise required to deliver complex data solutions. This role involves designing comprehensive training programs that keep employees updated on pharmaceutical industry trends and internal technologies. Anatolii Shapovalov drives initiatives that promote a high-performance culture and employee engagement across all international offices. By implementing robust performance management systems, the Chief Human Resources Officer aligns individual contributions with the broader corporate mission. The executive works to maintain a diverse and inclusive environment that attracts top-tier talent. Through strategic workforce planning, the Chief Human Resources Officer supports the company ability to scale operations effectively while maintaining the high standards of excellence expected in the pharmaceutical sector.